News
Trump's $3.3 trillion domestic agenda bill, passed by the House on Thursday, includes a significant victory for ...
Both well-established and small, clinical-stage pharma companies are investing heavily to be able to someday compete with ...
According to UBS, the company’s next major driver is the SURPASS cardiovascular outcomes trial. The bank added that Eli Lilly ...
A court-appointed special master recommended a bid backed by Gold Reserve and Koch over a rival hedge-fund offer. Krispy Kreme's top finance executive, Jeremiah Ashukian, is leaving the doughnut maker ...
Neurizon enters global licensing agreement with ElancoNeurizon Therapeutics (ASX:NUZ) has signed an exclusive global ...
In the ongoing case of Lilly LaRoque, the woman accused of killing 17-year-old Delaney Doherty in a head-on crash nearly two ...
VK2735 shows strong early weight loss data, positioning Viking Therapeutics as a potential third major player in the booming GLP-1 obesity drug market. Learn more on VKTX stock here.
The actor is raising awareness of clinical trials for cancer in partnership with “GMA” sponsor Eli Lilly & Co.
Source Bank provided a grant to the Lilly Center for Lakes & Streams to fund their library educational programs.
Eli Lilly and Company (NYSE:LLY) is one of the 13 best blue-chip stocks to buy, according to analysts. On June 30, RBC ...
21h
Zacks Investment Research on MSNHere's How Lilly's Non-Obesity Drugs are Contributing to Sales GrowthWhile Eli Lilly’s LLY top-line continues to touch new sky highs thanks to its blockbuster GLP-1 medicines — Mounjaro (for ...
Following its acquisition by Supernus Pharmaceuticals, Sage Therapeutics has let go of all of its remaining workforce, which ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results